Daniel S. Goldman bought Astellas Pharma Inc (PINK: ALPMY)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 3 trades in Astellas Pharma Inc (ALPMY) since 2023, 1 purchase and 2 sales, worth an estimated $73K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Daniel S. Goldman bought $15,001 - $50,000 of Astellas Pharma Inc (PINK: ALPMY) on February 27, 2023. Since that trade, ALPMY is up +18.75% against the S&P 500 up +91.32%, an outperformance of -72.57%.
Across these filings, Daniel S. Goldman has been a net seller of ALPMY (a buy-to-sell ratio of 0.50). The most recent disclosed ALPMY transaction shown was dated July 10, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Daniel S. Goldman's ALPMY trades vs the price
ALPMY is up +18.75% since Daniel S. Goldman bought on February 27, 2023, versus +91.32% for the S&P 500.
Performance since this trade
All Daniel S. Goldman ALPMY trades
Daniel S. Goldman & ALPMY trading FAQ
Is it legal for Daniel S. Goldman to trade Astellas Pharma Inc (ALPMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Astellas Pharma Inc (ALPMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman buy ALPMY?
Daniel S. Goldman disclosed a purchase of $15,001 - $50,000 of Astellas Pharma Inc (ALPMY) on February 27, 2023, according to public STOCK Act filings.
How has ALPMY performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman bought ALPMY on February 27, 2023, the stock is up +18.75%, versus +91.32% for the S&P 500 over the same period, an outperformance of -72.57%.
How many times has Daniel S. Goldman traded ALPMY?
Daniel S. Goldman has disclosed 3 ALPMY trades since 2023 (1 purchase and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ALPMY trades?
Quantellect tracks every disclosed congressional trade in Astellas Pharma Inc (ALPMY) on the Astellas Pharma Inc congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's ALPMY tradesAll congressional filings for Astellas Pharma IncDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.